Acacia Research (ACTG) Q1 2026 Earnings Transcript

Acacia reported Q1 revenue of $54.2 million, with operated segment revenue excluding IP up 7% sequentially to $53.5 million and adjusted EBITDA of $1.6 million. Benchmark set a quarterly revenue record of $18.7 million and expects >2.5x MOIC on the new Cherokee well, but a $9.7 million noncash hedge mark-to-market loss and a sharp decline in IP revenue to $0.7 million weighed on GAAP results. Deflecto showed early benefits from restructuring, including an estimated $2 million in annualized savings, while management held off on share repurchases in favor of reinvestment.

Analysis

The key read-through is that ACTG is becoming a cleaner sum-of-the-parts story, but the market is still likely discounting it as a volatile “lumpy earnings” vehicle because GAAP optics are being distorted by hedge accounting and the absence of an IP settlement. The better lens is cash conversion from the operating businesses: energy and manufacturing are now generating enough internal liquidity to self-fund growth capex and restructuring, which lowers the need for external capital and makes the equity de-risk over the next 2-3 quarters. That transition matters because it shifts the story from optionality on one-off monetizations to compounding from repeatable cash engines.

The second-order effect in Benchmark is that the hedge book, while painful on reported numbers, is actually increasing the strategic value of the asset base by allowing new wells to be financed off trapped operating cash rather than spot oil exposure. If crude stays firm, the short-term P&L noise can persist, but the operating leverage is now more visible in Q2/Q3 as Cherokee ramps and capital payback shows up in cash flow rather than earnings. That creates a setup where the stock can rerate even if reported EPS remains messy, because investors should start capitalizing next-year cash generation instead of quarterly accounting swings.

Deflecto is the underappreciated catalyst: the plant consolidation is a classic margin lag story, where costs are incurred now and savings arrive with a delay. If volumes merely stabilize, the incremental margin could be meaningfully better in the second half because the company has simultaneously removed capacity and reduced overhead; that is usually when consensus is most wrong, since the market extrapolates current EBITDA run-rate before savings hit. The housing and tariff exposures matter, but this is less a demand-collapse story than an absorption story, so any modest macro improvement could produce an outsized earnings rebound.

Contrarian view: the settlement-driven IP segment is no longer the right anchor for valuation, but its periodicity still creates headline risk and suppresses multiples. That’s exactly why the setup may be attractive for patient capital—if the market waits for visible IP revenue before assigning value, it may miss the rerating that comes from the operating businesses proving they can compound on their own. The main failure mode is if oil rolls over hard or Deflecto’s turnaround stalls, in which case the stock likely gets repriced back toward a cash-balance-with-no-growth multiple.

Key Decisions for Investors

• Long ACTG over the next 2-3 quarters: thesis is cash-flow compounding plus deferred Deflecto savings; target a rerating if Q2/Q3 shows Cherokee contribution and lower manufacturing cost structure. Risk/reward favors entry on weakness caused by hedge-mark-to-market noise.
• Buy ACTG common and hedge with a short WTI-linked basket or XLE puts for 2-4 months if you want to isolate execution rather than commodity beta. This protects against the main near-term drawdown scenario: a reversal in oil that worsens headline optics without improving strategic value.
• Pair trade: long ACTG / short a slower-growing industrial with similar restructuring narrative but less balance-sheet flexibility. The idea is to own the name where cash is funding transformation internally rather than relying on external financing.
• Short-dated call spread on ACTG into the next 1-2 earnings prints only if the stock sells off on hedge losses despite stable operating cash flow. That is the highest-probability catalyst for sentiment reversal as the market starts pricing Q2/Q3 rather than Q1 accounting.
• Avoid chasing DVN as a proxy for this setup; if your objective is leveraged oil exposure, ACTG has a more asymmetric path because internal reinvestment can amplify upside if crude stays constructive. Use DVN only as a partial hedge, not as the primary expression.